About Spidia
SPIDIA is a 4.5-year project, funded by the European Union FP7 programme to the value of 9 million Euros, which brings together a consortium of 16 leading academic institutions, international organisations and life sciences companies.
The project is coordinated by QIAGEN GmbH and aims to tackle the standardisation and improvement of pre-analytical procedures for in-vitro diagnostics. The proposed research and standardisation activities cover all steps from creation of evidence-based guidelines to creation of tools for the pre-analytical phase to testing and optimisation of these tools through the development of novel assays and biomarkers.
+++ LATEST NEWS +++ LATEST NEWS +++ LATEST NEWS +++ LATEST NEWS +++ LATEST NEWS +++
Read our most recent NEWSLETTER including important information about SPIDIA's project progress!
SPIDIA Newsletter 06
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
The SPIDIA cooperation partner OBBR (Office of Biorepository and Biospecimen Research, NCI) has released Standard Operating Procedures (SOPs) for the collection of normal human biospecimens. Please read more here.
+++ LATEST NEWS +++ LATEST NEWS +++ LATEST NEWS +++ LATEST NEWS +++ LATEST NEWS +++
This work is supported by funding under the Seventh Research Framework Programme of the European Union, (FP7-HEALTH-2007-1.2.5). This website has been created in the context of the SPIDIA project. All information is provided "as is" and no guarantee or warranty is given that the information fits for any particular purpose. The user thereof uses the information at its sole risk and liability.
